-
1.PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
标题翻译: PIPERIDINONDERIVATE ALS MDM2-HEMMER ZUR KREBSBEHANDLUNG公开(公告)号:EP2576510B1
公开(公告)日:2015-04-29
申请号:EP11726581.9
申请日:2011-06-03
申请人: Amgen Inc.
发明人: BARTBERGER, Michael David , GONZALEZ BUENROSTRO, Ana , BECK, Hilary Plake , CHEN, Xiaoqi , CONNORS, Richard Victor , DEIGNAN, Jeffrey , DUQUETTE, Jason , EKSTEROWICZ, John , FISHER, Benjamin , FOX, Brian Matthew , FU, Jiasheng , FU, Zice , GONZALEZ LOPEZ DE TURISO, Felix , GRIBBLE, JR., Michael William , GUSTIN, Darin James , HEATH, Julie Anne , HUANG, Xin , JIAO, Xianyun , JOHNSON, Michael , KAYSER, Frank , KOPECKY, David John , LAI, Sujen , LI, Yihong , LI, Zhihong , LIU, Jiwen , LOW, Jonathan Dante , LUCAS, Brian Stuart , MA, Zhihua , MCGEE, Lawrence , MCINTOSH, Joel , MCMINN, Dustin , MEDINA, Julio Cesar , MIHALIC, Jeffrey Thomas , OLSON, Steven Howard , REW, Yosup , ROVETO, Philip Marley , SUN, Daqing , WANG, Xiaodong , WANG, Yingcai , YAN, Xuelei , YU, Ming , ZHU, Jiang
IPC分类号: C07D211/40 , C07D401/04 , C07D401/06 , C07D407/04 , C07D407/06 , C07D409/04 , C07D413/06 , C07D417/06 , C07D471/20 , C07D279/02 , C07D401/12 , C07D498/08 , C07D498/20 , A61K31/4412 , A61P35/00
CPC分类号: C07D211/76 , C07D221/20 , C07D279/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/06 , C07D409/04 , C07D409/12 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/10 , C07D491/08 , C07D491/153 , C07D498/08 , C07D498/14 , C07D498/20
-
2.PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
标题翻译: PIPERIDINONDERIVATE AS MDM2抑制剂用于癌症治疗公开(公告)号:EP2576510A1
公开(公告)日:2013-04-10
申请号:EP11726581.9
申请日:2011-06-03
申请人: Amgen Inc.
发明人: BARTBERGER, Michael David , GONZALEZ BUENROSTRO, Ana , BECK, Hilary Plake , CHEN, Xiaoqi , CONNORS, Richard Victor , DEIGNAN, Jeffrey , DUQUETTE, Jason , EKSTEROWICZ, John , FISHER, Benjamin , FOX, Brian Matthew , FU, Jiasheng , FU, Zice , GONZALEZ LOPEZ DE TURISO, Felix , GRIBBLE, JR., Michael William , GUSTIN, Darin James , HEATH, Julie Anne , HUANG, Xin , JIAO, Xianyun , JOHNSON, Michael , KAYSER, Frank , KOPECKY, David John , LAI, Sujen , LI, Yihong , LI, Zhihong , LIU, Jiwen , LOW, Jonathan Dante , LUCAS, Brian Stuart , MA, Zhihua , MCGEE, Lawrence , MCINTOSH, Joel , MCMINN, Dustin , MEDINA, Julio Cesar , MIHALIC, Jeffrey Thomas , OLSON, Steven Howard , REW, Yosup , ROVETO, Philip Marley , SUN, Daqing , WANG, Xiaodong , WANG, Yingcai , YAN, Xuelei , YU, Ming , ZHU, Jiang
IPC分类号: C07D211/40 , C07D401/04 , C07D401/06 , C07D407/04 , C07D407/06 , C07D409/04 , C07D413/06 , C07D417/06 , C07D471/20 , C07D279/02 , C07D401/12 , C07D498/08 , C07D498/20 , A61K31/4412 , A61P35/00
CPC分类号: C07D211/76 , C07D221/20 , C07D279/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/06 , C07D409/04 , C07D409/12 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/10 , C07D491/08 , C07D491/153 , C07D498/08 , C07D498/14 , C07D498/20
摘要: The present invention provides MDM2 inhibitor compounds of Formula (I), wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
-
3.N-CYCLOHEXYL BENZAMIDES AND BENZENEACETAMIDES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASES 审中-公开
标题翻译: 苄氧基苯甲酸苄基胆碱酯酶抑制剂11-β-羟基甾烷二酮公开(公告)号:EP2121580A2
公开(公告)日:2009-11-25
申请号:EP07853344.5
申请日:2007-12-12
申请人: Amgen Inc.
发明人: YUAN, Chester, C. , HAN, Nianhe , LIU, Qingyian , MCMINN, Dustin , POWERS, Jay
IPC分类号: C07C233/81 , C07C233/74 , C07D213/40 , C07C233/23
CPC分类号: C07C233/74 , C07C237/22 , C07C271/12 , C07C2601/02 , C07C2601/14 , C07D213/30 , C07D213/40
摘要: The present invention provides N-cyclohexyl benzamide and benzeneacetamide compounds according to formula (I): where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, m, n, p, and q are as defined in the description; as well as pharmaceutical compositions comprising the same, methods of use of the compounds and compositions of the invention for the treatment of conditions associated with hydroxysteroid dehydrogenases (e.g., 11β-HSD1), and the use of the compounds of the invention in the preparation of medicaments for the treatment of hydroxysteroid dehydrogenase-associated conditions.
摘要翻译: 本发明提供了式(I)的N-环己基苯甲酰胺和苯乙酰胺化合物:其中R1,R2,R3,R4,R5,R6,R7,R8,R9,R10,R11,R12,R13,m,n,p ,和q如说明书中所定义; 以及包含其的药物组合物,使用本发明化合物和组合物的方法用于治疗与羟基类固醇脱氢酶(例如,11& -HSD1)相关的病症,以及本发明化合物在制剂中的用途 的用于治疗羟类固醇脱氢酶相关病症的药物。
-
4.BENZAMIDE DERIVATIVES AS MODULATORS OF 11BETA-HSD1 FOR TREATING DIABETES AND OBESITY 有权
标题翻译: 苯甲酰胺衍生物作为糖尿病和肥胖症的治疗11β-HSD1的调节剂公开(公告)号:EP2044004B1
公开(公告)日:2012-08-15
申请号:EP07795530.0
申请日:2007-05-31
申请人: Amgen Inc.
发明人: POWERS, Jay, P. , DEGRAFFENREID, Michael , JULIAN, Lisa , KAIZERMAN, Jacob , MCMINN, Dustin , REW, Yosup , SUN, Daqing , YAN, Xuelei , WANG, Zhulun
IPC分类号: C07C235/54 , C07D333/24 , C07D213/56 , C07D333/38 , C07D213/57 , A61K31/166 , C07D239/26 , A61K31/381 , C07D261/08 , A61K31/4406 , C07D273/08 , A61K31/415 , C07D307/94 , A61K31/4409
CPC分类号: C07C235/42 , A61K31/166 , A61K31/381 , A61K31/42 , A61K31/426 , A61K31/44 , A61K31/4965 , A61K31/50 , A61K31/505 , C07C237/22 , C07C237/24 , C07C237/42 , C07C255/31 , C07C255/46 , C07C255/60 , C07C271/12 , C07C271/20 , C07C307/06 , C07C2601/02 , C07C2601/14 , C07C2603/94 , C07D213/30 , C07D213/53 , C07D237/08 , C07D239/26 , C07D241/12 , C07D261/08 , C07D277/22 , C07D277/24
摘要: Benzamide derivatives of formula ( I ) are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders, formula (I), wherein R1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, and n are as defined herein.
-
5.FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS 审中-公开
标题翻译: CONDENSED吡啶,嘧啶化合物和三嗪化合物THAN细胞周期抑制剂公开(公告)号:EP2231656A1
公开(公告)日:2010-09-29
申请号:EP08867586.3
申请日:2008-12-18
申请人: Amgen Inc.
发明人: CONNORS, Richard, V. , DAI, Kang , EKSTEROWICZ, John , FAN, Pingchen , FISHER, Benjamin , FU, Jiasheng , LI, Kexue , LI, Zhihong , MCGEE, Lawrence, R. , SHARMA, Rajiv , WANG, Xiaodong , MCMINN, Dustin , MIHALIC, Jeffrey , DEIGNAN, Jeffrey
IPC分类号: C07D417/14 , C07D487/04 , C07D487/14 , C07D498/10 , C07D513/14 , A61P35/00 , A61K31/519
CPC分类号: C07D471/14 , A61K31/519 , A61K31/5377 , A61K31/5386 , C07D403/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D487/14 , C07D491/107 , C07D491/147 , C07D498/04 , C07D498/10 , C07D513/14
摘要: Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4-mediated disorders, such as cancer. The subject compounds are fused pyridine, pyrimide and triazine derivatives.
-
6.BENZAMIDE DERIVATIVES AS MODULATORS OF 11BETA-HSD1 FOR TREATING DIABETES AND OBESITY 有权
标题翻译: BENZAMIDDERIVATE ALS MODULATOREN VON 11BETA-HSD1 ZUR BEHANDLUNG VON糖尿病在OBESITAS公开(公告)号:EP2044004A2
公开(公告)日:2009-04-08
申请号:EP07795530.0
申请日:2007-05-31
申请人: Amgen Inc.
发明人: POWERS, Jay, P. , DEGRAFFENREID, Michael , JULIAN, Lisa , KAIZERMAN, Jacob , MCMINN, Dustin , REW, Yosup , SUN, Daqing , YAN, Xuelei , WANG, Zhulun
IPC分类号: C07C235/54 , C07D333/24 , C07D213/56 , C07D333/38 , C07D213/57 , A61K31/166 , C07D239/26 , A61K31/381 , C07D261/08 , A61K31/4406 , C07D273/08 , A61K31/415 , C07D307/94 , A61K31/4409
CPC分类号: C07C235/42 , A61K31/166 , A61K31/381 , A61K31/42 , A61K31/426 , A61K31/44 , A61K31/4965 , A61K31/50 , A61K31/505 , C07C237/22 , C07C237/24 , C07C237/42 , C07C255/31 , C07C255/46 , C07C255/60 , C07C271/12 , C07C271/20 , C07C307/06 , C07C2601/02 , C07C2601/14 , C07C2603/94 , C07D213/30 , C07D213/53 , C07D237/08 , C07D239/26 , C07D241/12 , C07D261/08 , C07D277/22 , C07D277/24
摘要: Benzamide derivatives of formula ( I ) are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders, formula (I), wherein R1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, and n are as defined herein.
摘要翻译: 描述了式I的苯甲酰胺衍生物,并且具有治疗用途,特别是在治疗糖尿病,肥胖症和相关病症和病症中:其中R1,R2,R3,R4,R5,R6,R7,R8和n如本文所定义。
-
-
-
-
-